Flinton Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
GIP
EMFAT
Flinton Capital Management's NEO Position: Q3 2019 in Review
Flinton Capital Management increased its NeoGenomics (NEO) stake by 19% in Q3 2019, buying an estimated $33.4K and bringing the position to 8,976 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #692.
Flinton Capital Management first reported a position in NEO in Q1 2019 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.
- Flinton Capital Management held 8,976 shares of NeoGenomics worth $172K as of Q3 2019.
- Flinton Capital Management bought 1,424 NeoGenomics shares in Q3 2019, an estimated $33.4K.
- NeoGenomics made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #692 holding.
- Flinton Capital Management first reported a position in NeoGenomics in Q1 2019 and has held it in 3 quarters since.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.
Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.